{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:09:33Z","timestamp":1778872173408,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1245\/s10434-026-19425-3","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:24:47Z","timestamp":1773177887000},"page":"5669-5681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of Lymph Node Thresholds as Prognostic Factors in Medullary Thyroid Cancer Staging"],"prefix":"10.1245","volume":"33","author":[{"given":"Christina V.","family":"Lindsay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto J.","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall P.","family":"Scheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadiza S.","family":"Kazaure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"6","key":"19425_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, et al. Revised American es for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335.","journal-title":"Thyroid."},{"key":"19425_CR2","doi-asserted-by":"publisher","unstructured":"Amin MB, Greene FL, Edge SB et al. (2017) The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017; 67(2):93-9. https:\/\/doi.org\/10.3322\/caac.21388","DOI":"10.3322\/caac.21388"},{"issue":"9","key":"19425_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/jamasurg.2017.1665","volume":"152","author":"MA Adam","year":"2017","unstructured":"Adam MA, Thomas S, Roman SA, Hyslop T, Sosa JA. Rethinking the current American joint committee on cancer TNM staging system for medullary thyroid cancer. JAMA Surg. 2017;152(9):869\u201376. https:\/\/doi.org\/10.1001\/jamasurg.2017.1665.","journal-title":"JAMA Surg"},{"issue":"7","key":"19425_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/archsurg.2009.122","volume":"144","author":"SY Boostrom","year":"2009","unstructured":"Boostrom SY, Grant CS, Thompson GB, et al. Need for a revised staging consensus in medullary thyroid carcinoma. Arch Surg. 2009;144(7):663\u20139. https:\/\/doi.org\/10.1001\/archsurg.2009.122.","journal-title":"Arch Surg"},{"issue":"4","key":"19425_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1245\/s10434-010-1363-y","volume":"18","author":"E Kandil","year":"2011","unstructured":"Kandil E, Gilson MM, Alabbas HH, Tufaro AP, Dackiw A, Tufano RP. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann Surg Oncol. 2011;18(4):1028\u201334. https:\/\/doi.org\/10.1245\/s10434-010-1363-y.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"19425_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","volume":"161","author":"RW Randle","year":"2017","unstructured":"Randle RW, Balentine CJ, Leverson GE, et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery. 2017;161(1):137\u201346. https:\/\/doi.org\/10.1016\/j.surg.2016.04.053.","journal-title":"Surgery"},{"issue":"3","key":"19425_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/cncr.26283","volume":"118","author":"HS Kazaure","year":"2012","unstructured":"Kazaure HS, Roman SA, Sosa JA. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer. 2012;118(3):620\u20137. https:\/\/doi.org\/10.1002\/cncr.26283.","journal-title":"Cancer"},{"issue":"22","key":"19425_CR8","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.3390\/cancers13225842","volume":"13","author":"J Kim","year":"2021","unstructured":"Kim J, Park J, Park H, et al. Metastatic lymph node ratio for predicting recurrence in medullary thyroid cancer. Cancers. 2021;13(22):5842.","journal-title":"Cancers"},{"issue":"6","key":"19425_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/bjs.11444","volume":"107","author":"A Machens","year":"2020","unstructured":"Machens A, Lorenz K, Dralle H. Prediction of biochemical cure in patients with medullary thyroid cancer. Br J Surg. 2020;107(6):695\u2013704. https:\/\/doi.org\/10.1002\/bjs.11444.","journal-title":"Br J Surg"},{"key":"19425_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/10507256251388406","author":"CV Lindsay","year":"2025","unstructured":"Lindsay CV, Wang F, Thomas SM, et al. Prognostic thresholds for lymph node metastasis in medullary thyroid cancer: a restricted cubic splines analysis. Thyroid. 2025. https:\/\/doi.org\/10.1177\/10507256251388406.","journal-title":"Thyroid"},{"issue":"1","key":"19425_CR11","doi-asserted-by":"publisher","first-page":"29808","DOI":"10.1038\/s41598-024-81644-z","volume":"14","author":"Y Gong","year":"2024","unstructured":"Gong Y, Gou F, Qin Q, Tian W, Zhao W, Zi D. Construction and validation of prognostic models for young cervical cancer patients: age stratification based on restricted cubic splines. Sci Rep. 2024;14(1):29808. https:\/\/doi.org\/10.1038\/s41598-024-81644-z.","journal-title":"Sci Rep"},{"issue":"6","key":"19425_CR12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s11605-018-3717-x","volume":"22","author":"P Gao","year":"2018","unstructured":"Gao P, Song Y, Yang Y, et al. What is the minimum number of examined lymph nodes after neoadjuvant therapy in rectal cancer? J Gastrointest Surg. 2018;22(6):1068\u201376. https:\/\/doi.org\/10.1007\/s11605-018-3717-x.","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"19425_CR13","doi-asserted-by":"publisher","first-page":"e214298","DOI":"10.1001\/jamasurg.2021.4298","volume":"156","author":"AT Nguyen","year":"2021","unstructured":"Nguyen AT, Luu M, Nguyen VP, et al. Development and validation of a modified pathologic nodal classification system for cutaneous melanoma. JAMA Surg. 2021;156(11):e214298\u2013e214298. https:\/\/doi.org\/10.1001\/jamasurg.2021.4298.","journal-title":"JAMA Surg."},{"issue":"1","key":"19425_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin."},{"issue":"12","key":"19425_CR15","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: A review. JAMA Oncology. 2017;3(12):1722\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6905.","journal-title":"JAMA Oncology."},{"issue":"6","key":"19425_CR16","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","volume":"26","author":"K Mallin","year":"2019","unstructured":"Mallin K, Browner A, Palis B, et al. Incident cases captured in the national cancer database compared with those in US population based central cancer registries in 2012\u20132014. Ann Surg Oncol. 2019;26(6):1604\u201312. https:\/\/doi.org\/10.1245\/s10434-019-07213-1.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"19425_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cncr.29761","volume":"122","author":"LX Jin","year":"2016","unstructured":"Jin LX, Moley JF. Surgery for lymph node metastases of medullary thyroid carcinoma: A review. Cancer. 2016;122(3):358\u201366. https:\/\/doi.org\/10.1002\/cncr.29761.","journal-title":"Cancer"},{"key":"19425_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fendo.2020.00090","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang J, Cheng X, Shen L, et al. The association between lymph node stage and clinical prognosis in thyroid cancer. Front Endocrinol (Lausanne). 2020;11:90. https:\/\/doi.org\/10.3389\/fendo.2020.00090.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"19425_CR19","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.ejso.2020.04.016","volume":"46","author":"T Rozenblat","year":"2020","unstructured":"Rozenblat T, Hirsch D, Robenshtok E, et al. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study. Eur J Surg Oncol. 2020;46(11):2023\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2020.04.016.","journal-title":"Eur J Surg Oncol."},{"issue":"40","key":"19425_CR20","doi-asserted-by":"publisher","first-page":"65937","DOI":"10.18632\/oncotarget.11725","volume":"7","author":"N Qu","year":"2016","unstructured":"Qu N, Shi RL, Lu ZW, et al. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis. Oncotarget. 2016;7(40):65937\u201345. https:\/\/doi.org\/10.18632\/oncotarget.11725.","journal-title":"Oncotarget."},{"issue":"2","key":"19425_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/SLA.0b013e318268301d","volume":"257","author":"A Machens","year":"2013","unstructured":"Machens A, Dralle H. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system. Ann Surg. 2013;257(2):323\u20139. https:\/\/doi.org\/10.1097\/SLA.0b013e318268301d.","journal-title":"Ann Surg."},{"issue":"2","key":"19425_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1210\/jc.2013-2942","volume":"99","author":"NH Esfandiari","year":"2014","unstructured":"Esfandiari NH, Hughes DT, Yin H, Banerjee M, Haymart MR. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. J Clin Endocrinol Metab. 2014;99(2):448\u201354. https:\/\/doi.org\/10.1210\/jc.2013-2942.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"19425_CR23","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1093\/oncolo\/oyad165","volume":"29","author":"Z Wang","year":"2024","unstructured":"Wang Z, Fan X, Zha X, et al. A proposed modified staging system for medullary thyroid cancer: A SEER analysis with multicenter validation. Oncologist. 2024;29(1):e59-67. https:\/\/doi.org\/10.1093\/oncolo\/oyad165.","journal-title":"Oncologist."},{"issue":"5","key":"19425_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1089\/thy.2021.0571","volume":"32","author":"Z Wang","year":"2022","unstructured":"Wang Z, Tang C, Wang Y, Yin Z, Rixiati Y. Inclusion of the number of metastatic lymph nodes in the staging system for medullary thyroid cancer: Validating a modified american joint committee on cancer tumor-node-metastasis staging system. Thyroid\u00ae. 2022;32(5):536\u201343. https:\/\/doi.org\/10.1089\/thy.2021.0571.","journal-title":"Thyroid\u00ae"},{"issue":"1","key":"19425_CR25","doi-asserted-by":"publisher","first-page":"e13884","DOI":"10.1097\/md.0000000000013884","volume":"98","author":"K Meng","year":"2019","unstructured":"Meng K, Luo H, Chen H, Guo H, Xia W. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database. Medicine. 2019;98(1):e13884. https:\/\/doi.org\/10.1097\/md.0000000000013884.","journal-title":"Medicine"},{"issue":"9","key":"19425_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","volume":"29","author":"L Desquilbet","year":"2010","unstructured":"Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037\u201357. https:\/\/doi.org\/10.1002\/sim.3841.","journal-title":"Stat Med"},{"issue":"5","key":"19425_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3322\/caac.21339","volume":"66","author":"MW Kattan","year":"2016","unstructured":"Kattan MW, Hess KR, Amin MB, et al. American joint committee on cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016;66(5):370\u20134. https:\/\/doi.org\/10.3322\/caac.21339.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"19425_CR28","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/hed.27181","volume":"44","author":"A Machens","year":"2022","unstructured":"Machens A, Lorenz K, Weber F, Dralle H. Superiority of metastatic lymph node ratio over number of node metastases and TNM\/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer. Head Neck. 2022;44(12):2717\u201326. https:\/\/doi.org\/10.1002\/hed.27181.","journal-title":"Head Neck"},{"issue":"11","key":"19425_CR29","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1245\/s10434-021-09683-8","volume":"28","author":"PM Spanheimer","year":"2021","unstructured":"Spanheimer PM, Ganly I, Chou JF, et al. Prophylactic lateral neck dissection for medullary thyroid carcinoma is not associated with improved survival. Ann Surg Oncol. 2021;28(11):6572\u20139. https:\/\/doi.org\/10.1245\/s10434-021-09683-8.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"19425_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12020-024-03897-y","volume":"85","author":"Y Hou","year":"2024","unstructured":"Hou Y, Yang Y, Chen G, et al. The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: A retrospective multicenter cohort study. Endocrine. 2024;85(2):827\u201336. https:\/\/doi.org\/10.1007\/s12020-024-03897-y.","journal-title":"Endocrine"},{"issue":"6","key":"19425_CR31","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95(6):2655\u201363. https:\/\/doi.org\/10.1210\/jc.2009-2368.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"19425_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/thy.2017.0514","volume":"28","author":"H-S Oh","year":"2018","unstructured":"Oh H-S, Kwon H, Song E, et al. Preoperative clinical and sonographic predictors for lateral cervical lymph node metastases in sporadic medullary thyroid carcinoma. Thyroid\u00ae. 2018;28(3):362\u20138. https:\/\/doi.org\/10.1089\/thy.2017.0514.","journal-title":"Thyroid\u00ae"},{"issue":"6","key":"19425_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/cen.12657","volume":"83","author":"JH Yang","year":"2015","unstructured":"Yang JH, Lindsey SC, Camacho CP, et al. Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer. Clin Endocrinol (Oxf). 2015;83(6):938\u201342. https:\/\/doi.org\/10.1111\/cen.12657.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"49","key":"19425_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jncimonographs\/lgu024","volume":"2014","author":"AB Mariotto","year":"2014","unstructured":"Mariotto AB, Noone AM, Howlader N, et al. Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr. 2014;2014(49):145\u201386. https:\/\/doi.org\/10.1093\/jncimonographs\/lgu024.","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19425-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:45Z","timestamp":1778869665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19425-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19425"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19425-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Christina Lindsay, Samantha Thomas, Alberto Monreal, Randall Scheri, and Hadiza Kazaure have no conflicts of interest to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}